Liminatus Pharma: And Item 9.01 Of The Current Report On Form 8k Filed By Liminatus Pharma,inc. (formerly Known As Iris Parent Holding Corp.), A Delaware Corporation (the “company” Or “parentco”), On May 6, 2025 (the “original Report”), In Which The Company Reported, Among Other Events, The Completion Of The Business Combination (as Defined In The Original Report) On April 30, 2025, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Liminatus Pharma, Inc.
• Registration country
  USA
• Industry
  Miscellaneous Healthcare: Products and Services
• М/S&P/F
  *** / *** / ***